Science + Technology

UCLA Laser Refractive Center Seeks Patients for a Clinical Trial of Experimental Implantable Lens for Nearsightedness


The UCLA LaserRefractive Center at the Jules Stein Eye Institute seeks participants for athree-year research study of an experimental implantable lens for thecorrection of myopia, commonly referred to as nearsightedness.

The Phase II clinical trial,performed under the supervision of the FDA, will evaluate the effectiveness ofthe Phakic 6 H2 lens in the treatment of myopia and to determine the potentialrisks of the lens. During the procedure, the lens is implanted inside the eye,between the cornea and the iris. For the purposes of the study, only one eyewill receive the new lens. The lens and implantation procedure are similar tothe intraocular lens and surgical techniques utilized in modern cataractsurgery.

Individuals whoare good candidates for standard refractive surgeries are not eligible toparticipate in this study. Qualified patients should be in good health, betweenthe ages of 21 and 55, free of eye disease and without prior eye surgeries.Additionally, a thorough eye examination and several diagnostic studies will beperformed before a patient is considered a candidate for the surgery. Patientswill not be paid for their participation in the study. Participants areresponsible for the cost of the surgery, including the lens, which is $3,500per eye. To schedule a complementary evaluation to determine if you areeligible to enroll in this study, call (310) 825‑2737.

The Jules SteinEye Institute at UCLA is a world-recognized leader in patient care, educationand research. The institute records more than 70,000 visits each year frompatients with all categories of eye diseases and disorders and consistentlyranks as the No. 1 eye care center in the Western United States in U.S. News& World Report's annual survey of best hospitals.

The UCLA Laser RefractiveCenter at the Jules Stein Eye Institute offers a full range of procedures forcorrection of nearsightedness, farsightedness, presbyopia and astigmatism.Since its inception, the center has improved the vision of more than 9,500patients and trained more than 1,000 doctors in a wide range of procedures.



Media Contact